Navigation Links
Tranziger Announces Formation of Global Advisory & Development Team
Date:10/7/2009

LONDON and WASHINGTON, Oct. 7 /PRNewswire/ -- Tranziger Limited announced today the formation of its global advisory and business team to advise and assess companies in the life sciences and healthcare sectors to execute strategic transactions and realise and optimise value from their portfolios in these turbulent times. Tranziger Limited is headquartered in London, England, UK and has offices in Washington, DC and Edinburgh.

The Tranziger team will be attending the upcoming BioPartnering Europe conference from October 12-14 at the Queen Elizabeth Conference Centre in London.

Established in early 2009 by a group of senior, highly experienced international corporate business transactional professionals, Tranziger aims to help the managers and owners of small and mid-tier companies in the Biotechnology, Pharmaceutical, Diagnostics and Medical Technology sectors realise value in the currently challenging global economic environment. The group offers strategic transaction advisory and execution services including Mergers and Acquisitions, Corporate and Commercial Development, Corporate Partnering, technical due diligence, and strategic R&D consultancy. Tranziger also has a proprietary service for venture formation, development and commercialisation utilised by larger corporations, universities, government agencies and investment organizations.

Tranziger distinguishes itself from other groups by the fact that its team members originate from the same peer group as many of their prospective clients and deal partners, combining scientific acumen with seasoned experience at the transactional coalface. The group's geographical reach extends to Europe, North America and Asia Pacific, offering scope for a wider base of creative solutions and deal potential.

Dr. V. Paul Gerskowitch, Executive Chairman of Tranziger, said, "The global downturn has caused an intense reevaluation of business models and priorities. Very many newer spinout and mid-tier companies will struggle to survive, doomed by an inability to raise sufficient capital, partner or grow organically. At the same time, larger companies are increasingly staking claims earlier in all phases of technology development."

Neil J. Campbell, Managing Director, North America, said, "As investors focus ever more on those companies with quality data and revenue potential, the life science and healthcare sectors will likely selectively consolidate around those with top quality offerings. Increasingly, there will be a shift away from financial engineers to business builders. This will be brought about by the rise of so-called third age entrepreneurs and the need to derive more value from technology portfolios, thus spreading the risk. Proactive portfolio management and product/technology life cycle management, achieved via Tranziger's Portfolio Partnering model, will become an ever more urgent and value-driving activity for companies."

About Tranziger Limited

Tranziger was established in 2009 by a group of senior, highly experienced international corporate business transactional professionals. Tranziger aims to help the managers and owners of small and mid-sized companies in the Biotechnology, Pharmaceutical, Diagnostics and Medical Technology sectors realise value in the currently challenging global economic environment. The group offers strategic transaction advisory and execution services including Mergers and Acquisitions, Corporate and Commercial Development, Corporate Partnering, technical due diligence, and strategic R&D consultancy. Tranziger also has a proprietary service for venture formation, development and commercialization utilised by larger corporations, universities, government agencies and investment organizations. Further information about Tranziger can be found at www.tranziger.com.

    Contact:
    Tranziger, Limited
    +44 20 8663 3472
    Dr. Paul Gerskowitch, Executive Chairman
    gerskowitch@tranziger.com
    or
    Neil Campbell, Managing Director North American Operations
    +1 301 792 4345
    campbell@tranziger.com

    Tiberend Strategic Advisors, Inc.
    212-827-0020

    Andrew Mielach
    amielach@tiberendstrategicadvisors.com
    or
    Farrell Denby
    fdenby@tiberendstrategicadvisors.com

SOURCE Tranziger Limited


'/>"/>
SOURCE Tranziger Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Telesoft Announces Advanced Dispute Management Capabilities with Version 9.5
2. Cardiovascular Systems Announces Plans for Second Manufacturing Facility - New Facility Expands CSI's Capacity to Produce Peripheral Arterial Disease Systems
3. Health Department Announces First Doses of H1N1 Vaccine Arrive in Pennsylvania
4. Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports
5. NIH announces expansion of Rare Diseases Clinical Research Network
6. bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID(R) Molecular Cancer Classifier in United Kingdom, Ireland and Middle East Countries
7. One Source Industries Announces Promotion
8. The Symphony Guild Announces Artist Lineup for 2009 Event
9. Hanger Orthopedic Group, Inc. Announces Third Quarter 2009 Earnings Release Conference Call
10. China-Biotics, Inc. Announces Closing of Public Offering of Common Stock
11. Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017   Divoti USA will ... to the standard of the latest FDA requirements, which stipulates new ... Anyone in need of Medical ID jewelry such as Medical ... are engraved in terms of the new FDA requirements ... Divoti offers this dark ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
Breaking Medicine Technology: